#USA #New York #Securities Fraud #Levi Korsinsky #PepGen Inc

Important Class Action Lawsuit for PepGen Inc. Investors

Levi & Korsinsky, LLP has issued a crucial notice to investors of PepGen Inc. (NASDAQ: PEPG), informing them about a pending class action lawsuit related to alleged securities fraud that occurred between March 7, 2024, and March 3, 2025. This litigation aims to recoup losses experienced by shareholders who were misled by false statements regarding the company's operations and product efficacy.

Overview of the Lawsuit

The lawsuit highlights that significant misrepresentations regarding PepGen's lead product candidate, PGN-EDO51, may have misled investors about its effectiveness and safety. Furthermore, the allegations suggest that the Phase Two, CONNECT2 study, a crucial step toward U.S. Food and Drug Administration (FDA) approval, was fraught with dangers that were not adequately disclosed to investors. Due to these misleading statements, there is a strong indication that PepGen may need to halt the CONNECT2 study, affecting the clinical and commercial prospects of PGN-EDO51. Consequently, public statements made by the defendants are described as materially false and misleading throughout the relevant period.

What Investors Need to Know

For investors who have suffered losses in PepGen Inc. shares during the specified timeframe, the deadline for acting is fast approaching. Interested parties have until August 8, 2025, to apply for the status of lead plaintiff in this class action case. Importantly, participation in this lawsuit does not require individuals to serve as a lead plaintiff to share in any potential recovery from the case.

No Cost for Participation

One of the key points of participation in this class action lawsuit is that there are no out-of-pocket costs or fees required from investors. This means that if you are deemed a class member, you could potentially receive compensation for your losses without having to pay any upfront costs. Levi & Korsinsky emphasizes that there is absolutely no obligation to participate if you decide not to do so.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has garnered a robust reputation over the past 20 years, securing hundreds of millions in settlements for investors who have suffered due to misleading corporate practices. The firm has consistently proven its expertise in complex securities litigation, having made it into the Top 50 Report of ISS Securities Class Action Services for seven consecutive years.

Contact Information

If you believe you may be affected by this lawsuit or would like more information, you can reach Joseph E. Levi, Esq. at Levi & Korsinsky, LLP via email or by telephone:

• - Email: info@zlk.com
• - Phone: (212) 363-7500

Educate Yourself

Investors are encouraged to stay informed about this legal proceeding, as well as their rights and options regarding participation. To learn more details regarding the case and for guidance on filing claims, follow the link below.

Learn More Here

In times of uncertainty, being informed and proactive is crucial for investors. Don't miss this opportunity to seek justice and possible compensation for your losses in PepGen Inc.